Sagimet Biosciences Inc. Series A Common Stock (SGMT) valuation · $403.2M cap
Sagimet Biosciences Inc. Series A Common Stock (SGMT) $403.2M cap.
| Metric | Value |
|---|---|
| Market cap | $403.2M |
| Revenue | $2.0M |
| P/S | 201.6 |
| P/B | 3.9 |
SGMT valuation FAQ
What is SGMT's market cap?
Sagimet Biosciences Inc. Series A Common Stock (SGMT) market cap is $403.2M on the latest cached fundamentals snapshot.
What is SGMT's latest revenue?
Latest cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) revenue was $2.0M. Statements: https://lician.com/financials/sgmt
What is SGMT's price-to-sales ratio?
Sagimet Biosciences Inc. Series A Common Stock (SGMT) price-to-sales (P/S) is 201.6, cached market cap $403.2M divided by revenue $2.0M.
What is SGMT's price-to-book ratio?
Sagimet Biosciences Inc. Series A Common Stock (SGMT) price-to-book (P/B) is 3.9 on the latest cached fundamentals snapshot.
How many SGMT valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Sagimet Biosciences Inc. Series A Common Stock (SGMT): Market cap, Revenue, P/S, and P/B.
Where is SGMT valuation listed?
Cached valuation multiples for Sagimet Biosciences Inc. Series A Common Stock (SGMT) are listed at https://lician.com/valuation/sgmt.
Not investment advice. Cached rows, not a live tape.